 "pharma, medicines, drugs")
Shares of Strides Pharma Science surged 15 per cent to Rs 432 on the BSE on Wednesday after the company announced that it has developed and commercialized Favipiravir Antiviral tablets. The product has demonstrated positive outcomes in Covid-19 treatment globally. It is a generic version of Avigan of Toyama Chemical, Japan.
Favipiravir is an antiviral medication that was initially developed to treat influenza in Japan. In February 2020, post the outbreak of Novel Coronavirus (Covid-19), Favipiravir was studied in China and several other countries as an experimental treatment of Covid-19. The drug has demonstrated positive outcomes, including a reduction
Favipiravir is an antiviral medication that was initially developed to treat influenza in Japan. In February 2020, post the outbreak of Novel Coronavirus (Covid-19), Favipiravir was studied in China and several other countries as an experimental treatment of Covid-19. The drug has demonstrated positive outcomes, including a reduction
